Nephrotic syndrome in childhood. Management and treatment in patients with minimal change disease, mesangial proliferation, or focal glomerulosclerosis.
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D002699:Chlorambucil / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D005260:Female; D005921:Glomerulonephritis / Q000628:therapy*; D005923:Glomerulosclerosis, Focal Segmental / Q000209:etiology / Q000628:therapy*; D006801:Humans; D008297:Male; D009402:Nephrosis, Lipoid / Q000209:etiology / Q000628:therapy*; D009404:Nephrotic Syndrome / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D011241:Prednisone / Q000627:therapeutic use; D012008:Recurrence
D004232:Diuretics; D002699:Chlorambucil; D003520:Cyclophosphamide; D011241:Prednisone